Finance

Results: 26173-26184 of 40560

PR Newswire associated0

Starlizard Integrity Services identifies 79 suspicious football matches played globally in first half of 2024

ELECTION BOUNCE SIGNALS SURGE IN SMALL BUSINESS CONFIDENCE AS GROWTH OUTLOOK HITS A TWO-YEAR HIGH

PR Newswire associated0

BULDAK CELEBRATES SUCCESSFUL RETURN TO DENMARK WITH SPICY FERRY PARTY

PR Newswire associated0

The Board of Directors of the Prince Mohammed bin Salman Royal Reserve Development Authority Announces the Launch of the Integrated Development Management Plan (IDMP)

PR Newswire associated0

Giant Pandas Make Public Debut During Historic Day at San Diego Zoo

Enstar to Enter $376 Million Loss Portfolio Transfer with QBE

Suzano reports Adjusted EBITDA of R$6.3 billion in the second quarter of 2024

ACCESSWIRE logo

Innodata Reports Second Quarter 2024 Results; Record 66% Revenue Growth Year-Over-Year

Atlantica Holds Shareholders’ Meetings to Approve its Acquisition by Energy Capital Partners and Co-Investors

Business Wire logo

Prothena Reports Second Quarter 2024 Financial Results and Business Highlights

ACCESSWIRE logo

Issuer Direct Reports Second Quarter 2024 Results

Bifidobacterium infantis M-63 is a unique probiotic strain of human-residential bifidobacteria (HRB) – bifidobacteria that naturally reside in the human gut – and is renowned for its ability to utilize human milk oligosaccharides (HMO) found in breast milk, significantly improving the intestinal environment of healthy full-term infants. (Graphic: Business Wire)

Morinaga Milk Obtains the Registration of "New Food Ingredient" in China for use of its Probiotic Bifidobacterium infantis M-63 in Infant Foods